Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC on May 16, 2023. As part of the consideration, Plandai Biotechnology will issue it's all authorized, issued, and outstanding preferred common shares and common stock. BP International-will become a wholly-owned subsidiary of PLPL and conduct operations under the Plandaí Biotechnology corporate entity. ByoPlanet's Chief Executive Officer, Rick O'Shea, will step into the role as Chief Executive Officer of Plandai moving forward.

As of May 17, 2023, Plandaí Biotechnology, Inc. completed the acquisition of ByoPlanet International, LLC.

Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC on August 1, 2023. The deal got cancelled due to the material failure of consideration in the transaction, despite diligent efforts and ongoing communications, conditions subsequent to the closing were unmet, and essential considerations were not settled. The rescission will render the material definitive agreement null and void, and both parties will revert to their pre-agreement status. The Company's decision to rescind the agreement was approved by both a majority of the Plandai shareholders eligible to vote and the board of directors.